Yayınlar & Eserler

Yayın Ağı
Makaleler 22
Tümü (22)
SCI-E, SSCI, AHCI (15)
SCI-E, SSCI, AHCI, ESCI (19)
ESCI (4)
Scopus (22)
TRDizin (8)

1. Ceftazidime-Avibactam: A Retrospective Analysis of Multicenter Real-World Data and Factors Affecting Mortality

Aktuğ-Demir N., Temoçin F., Ural O., GÜLTEN E., İNAL A. S., KADER Ç., et al.
Infectious Diseases and Clinical Microbiology , cilt.7, sa.4, ss.406-420, 2025 (ESCI, Scopus, TRDizin) Creative Commons License

2. Impact of the COVID-19 pandemic on surgical site infections: a multi-center study evaluating incidence, pathogen distribution, and antimicrobial resistance patterns

Keske Ş., SARGIN ALTUNOK E., Azak E., GÜLTEN E., ARSLAN GÜLEN T., ATAMAN HATİPOĞLU Ç., et al.
Antimicrobial Resistance and Infection Control , cilt.14, sa.1, 2025 (SCI-Expanded, Scopus)

3. Impact of the COVID-19 Pandemic on CLABSI Rates and Antibiotic Resistance: A Multicenter Study in Türkiye

SARGIN ALTUNOK E., Keske Ş., BATIREL A., Bilgin H., GÜLTEN E., Menekşe Ş., et al.
Infectious Diseases and Clinical Microbiology , cilt.7, sa.3, ss.273-282, 2025 (ESCI, Scopus, TRDizin) Creative Commons License

4. Evaluation of Treatment Response in Chronic Hepatitis C Patients Receiving Sofosbuvir/Velpatasvir/Voxilaprevir: A Multicenter Real-World Experience from Türkiye

BİNAY U. D., KARAKEÇİLİ F., AYGEN B., KILINÇ TOKER A., ÇELİK İ., Demirtürk N., et al.
Viruses , cilt.17, sa.7, 2025 (SCI-Expanded, Scopus) Creative Commons License

5. Seroprevalence of Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Among People Who Use Drugs in Turkey

ASAN A., Turan C., ŞENORMANCI Ö., Sayar M. S., METİN S., HAKYEMEZ İ. N.
Open Forum Infectious Diseases , cilt.12, sa.4, 2025 (SCI-Expanded, Scopus)

6. Diagnostic approach of tuberculous lymphadenitis in a multicenter study

YENİLMEZ E., Özakinsel D., KÖSE A., Olçar Y., Duman Z., Ceylan M. R., et al.
Journal of Infection in Developing Countries , cilt.18, sa.5, ss.742-750, 2024 (SCI-Expanded, Scopus)

7. Treatment initiation rates of patients with positive anti-hepatitis C virus results in tertiary hospitals in Turkey

Çelen M. K., Şengel B. E., KAYA Ş., Demirtürk N., AZAP A., Pullukçu H., et al.
Journal of Infection in Developing Countries , cilt.18, sa.3, ss.441-449, 2024 (SCI-Expanded, Scopus) Creative Commons License

8. Effector memory T cell subset CD45RA−CCR7−CD27−CD28− EM3 increases in direct proportion to the disease severity of COVID-19

Kizmaz M. A., ŞİMŞEK A., Bozkurt T., Cagan E., Dombaz F., TEZCAN DURMUŞ G., et al.
Scandinavian Journal of Immunology , cilt.97, sa.1, 2023 (SCI-Expanded, Scopus)

9. Management of Chronic Hepatitis B Infection: A Consensus Report of the Study Group for Viral Hepatitis of the Turkish Society of Clinical Microbiology and Infectious Diseases-2023 Update Kronik Hepatit B İnfeksiyonunun Yönetimi: Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Derneği Viral Hepatit Çalışma Grubu Uzlaşı Raporu-2023 Güncellemesi

Demirtürk N., KÖSE A., Ural O., ASAN A., BARUT H. Ş., Sümer Ş., et al.
Klimik Dergisi , cilt.36, ss.1-22, 2023 (ESCI, Scopus, TRDizin) Creative Commons License

10. Epidemiological and Prognostic Factors in Pregnancy Diagnosis of SARS-CoV-2 SARS-COV-2 Tanılı Gebelerde Epidemiyolojik ve Prognostik Faktörler

Gümüş A., Karaşin S. S., Sayar M. S., Göktaş S. Y., ASAN A., Akça M. Ö., et al.
Sakarya Medical Journal , cilt.12, sa.4, ss.703-711, 2022 (Scopus, TRDizin)

11. Assessment of CD39 expression in regulatory T-cell subsets by disease severity in adult and juvenile COVID-19 cases

ŞİMŞEK A., Kizmaz M. A., Cagan E., Dombaz F., TEZCAN DURMUŞ G., ASAN A., et al.
Journal of Medical Virology , cilt.94, sa.5, ss.2089-2101, 2022 (SCI-Expanded, Scopus)

12. Estimated glomerular filtration rate in identifying illness severity in newly admitted patients with COVID-19: A single-center study

ÜSTÜNDAĞ Y., Engindeniz F. T., HUYSAL K., Kologlu R. F., ASAN A., KOCA N., et al.
International Journal of Medical Biochemistry , cilt.5, sa.1, ss.44-48, 2022 (Scopus, TRDizin)

13. Demographic, clinical and laboratory characteristics for differential diagnosis of peripheral lymphadenopathy (LAP) and the etiologic distribution of LAP in adults; a multicenter, nested case–control study including 1401 patients from Turkey

YENİLMEZ E., Verdi Y., Ilbak A., Demirkiran B. C., Duman Z., BOZKURT F., et al.
Internal and Emergency Medicine , cilt.16, sa.8, ss.2139-2153, 2021 (SCI-Expanded, Scopus)

14. Changes in antimicrobial resistance and outcomes of health care–associated infections

AYDIN M., Azak E., Bilgin H., Menekse S., ASAN A., Mert H. T. E., et al.
European Journal of Clinical Microbiology and Infectious Diseases , cilt.40, sa.8, ss.1737-1742, 2021 (SCI-Expanded, Scopus)

15. Real-world data from Turkey: Is sofosbuvir/ledipasvir with or without ribavirin treatment for chronic hepatitis C really effective?

Demirtürk N., AYGEN B., ÇELİK İ., Mıstık R., AKHAN S., BARUT H. Ş., et al.
Turkish Journal of Gastroenterology , cilt.32, sa.2, ss.155-163, 2021 (SCI-Expanded, Scopus, TRDizin)

16. Evaluation of hepatitis b seroprevalence and hepatitis b reactivation frequency in rheumatology patients using biological drug therapy Biyolojik ilaç tedavisi kullanmakta olan romatoloji hastalarında hepatit b seroprevalansının ve hepatit b reaktivasyonu sıklığının değerlendirilmesi

AYAR K., ASAN A., Hattatoğlu T. D.
Klimik Dergisi , cilt.34, sa.1, ss.42-49, 2021 (ESCI, Scopus) Creative Commons License

17. The Relationship between COVID-19 Severity and Bacillus Calmette-Guérin (BCG)/ Mycobacterium tuberculosis exposure history in healthcare workers: a multi-center study

Torun S., Ozkaya S., Şen N., Kanat F., Karaman I., Yosunkaya S., et al.
Pathogens and Global Health , cilt.115, sa.6, ss.405-411, 2021 (SCI-Expanded, Scopus)

18. Abnormal Dispersion of Ventricular Repolarization as a Risk Factor in Patients with Human Immunodeficiency Virus: Tp-e Interval, Tp-e/QTc Ratio

Unal Evren E., Cekirdekci E. I., Evren H., Suer K., Sarigul Yildirim F., ASAN A., et al.
Medical Principles and Practice , cilt.29, sa.6, ss.544-550, 2020 (SCI-Expanded, Scopus)

19. Prevalence of pressure ulcers in hospitalized adult patients in Bursa, Turkey: A multicentre, point prevalence study

Sayan H. E., Girgin N. K., ASAN A.
Journal of Evaluation in Clinical Practice , cilt.26, sa.6, ss.1669-1676, 2020 (SCI-Expanded, Scopus)

20. Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: The Turkey experience experience

AYGEN B., Demirtürk N., YILDIZ O., Çelen M. K., Çelik İ., BARUT H. Ş., et al.
Turkish Journal of Gastroenterology , cilt.31, sa.4, ss.305-317, 2020 (SCI-Expanded, Scopus, TRDizin)

21. Management of chronic hepatitis C virus infection: A consensus report of the study group for viral hepatitis of the Turkish society of clinical microbiology and infectious diseases-2017 update Kronik hepatit C virusu infeksiyonunun yönetimi: Türk klinik mikrobiyoloji ve infeksiyon hastaliklari derneği viral hepatit çalişma grubu uzlaşi raporu-2017 güncellemesi

AYGEN B., Demirtürk N., Türker N., ASAN A., Eraksoy H., GÜRBÜZ Y., et al.
Klimik Dergisi , cilt.30, sa.Special Issue 1, ss.2-35, 2017 (Scopus, TRDizin)

22. Evaluation of tularaemia courses: A multicentre study from Turkey

ERDEM H., ÖZTÜRK ENGİN D., YEŞİLYURT M. K., Karabay O., ELALDI N., Celebi G., et al.
Clinical Microbiology and Infection , cilt.20, sa.12, 2014 (SCI-Expanded, Scopus)
Metrikler

Yayın

22

Yayın (WoS)

19

Yayın (Scopus)

22

H-İndeks (WoS)

7

Atıf (Scopus)

180

H-İndeks (Scopus)

6

Atıf (TrDizin)

16

H-İndeks (TrDizin)

3

Atıf (Diğer Toplam)

16

Proje

1

Tez Danışmanlığı

1

Açık Erişim

7